Back to top
more

Burning Rock Biotech (BNR)

(Delayed Data from NSDQ)

$0.85 USD

0.85
22,717

0.00 (0.00%)

Updated Apr 26, 2024 11:37 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (141 out of 252)

Industry: Technology Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for BNR

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Burning Rock Biotech Limited Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 87 134 236 351 -99,999
Receivables 18 16 14 14 NA
Notes Receivable NA 0 0 0 NA
Inventories 10 19 19 10 NA
Other Current Assets 10 14 16 12 NA
Total Current Assets 125 183 286 387 NA
Net Property & Equipment 19 37 51 17 NA
Investments & Advances 0 0 0 0 NA
Other Non-Current Assets 1 1 0 0 NA
Deferred Charges NA 0 0 0 NA
Intangibles 0 0 1 1 NA
Deposits & Other Assets 1 3 7 4 NA
Total Assets 146 230 358 408 NA
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable NA 0 0 0 NA
Accounts Payable 3 7 10 5 NA
Current Portion Long-Term Debt NA 0 0 6 NA
Current Portion Capital Leases NA 0 0 1 NA
Accrued Expenses 15 25 20 13 NA
Income Taxes Payable NA 0 0 0 NA
Other Current Liabilities 19 22 23 12 NA
Total Current Liabilities 37 60 58 37 NA
Mortgages NA 0 0 0 NA
Deferred Taxes/Income NA 0 0 0 NA
Convertible Debt NA 0 0 0 NA
Long-Term Debt NA 0 0 0 NA
Non-Current Capital Leases NA 0 0 0 NA
Other Non-Current Liabilities 1 1 2 0 NA
Minority Interest (Liabilities) NA 0 0 0 NA
Total Liabilities 38 62 68 37 NA
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock NA 0 0 0 NA
Common Stock (Par) 0 0 0 0 NA
Capital Surplus 683 664 672 614 NA
Retained Earnings -543 -464 -350 -217 NA
Other Equity -23 -24 -32 -26 NA
Treasury Stock 9 9 0 0 NA
Total Shareholder's Equity 108 168 290 371 NA
Total Liabilities & Shareholder's Equity 146 230 358 408 NA
Total Common Equity 100,107 168 290 371 0
Shares Outstanding 102.60 102.60 105.10 104.50 NA
Book Value Per Share 975.70 1.64 2.76 3.55 0.00

Fiscal Year End for Burning Rock Biotech Limited Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 -99,912 87 101 117
Receivables NA 18 19 20 18
Notes Receivable NA NA 0 0 0
Inventories NA 10 12 14 17
Other Current Assets NA 10 14 15 14
Total Current Assets NA 125 133 150 166
Net Property & Equipment NA 19 22 26 32
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 1 1 1 1
Deferred Charges NA NA 0 0 0
Intangibles NA 0 0 0 0
Deposits & Other Assets NA 1 1 2 2
Total Assets NA 146 160 184 206
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA NA 0 0 0
Accounts Payable NA 3 3 3 3
Current Portion Long-Term Debt NA NA 0 0 0
Current Portion Capital Leases NA NA 0 0 0
Accrued Expenses NA 15 15 22 21
Income Taxes Payable NA NA 0 0 0
Other Current Liabilities NA 19 20 20 23
Total Current Liabilities NA 37 40 49 52
Mortgages NA NA 0 0 0
Deferred Taxes/Income NA NA 0 0 0
Convertible Debt NA NA 0 0 0
Long-Term Debt NA NA 0 0 0
Non-Current Capital Leases NA NA 0 0 0
Other Non-Current Liabilities NA 0 0 1
Minority Interest (Liabilities) NA NA 0 0 0
Total Liabilities NA 38 42 50 54
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA NA 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 683 655 649 679
Retained Earnings NA -543 -506 -485 -493
Other Equity NA -23 -22 -22 -25
Treasury Stock NA 9 9 9 9
Total Shareholder's Equity NA 108 118 133 152
Total Liabilities & Shareholder's Equity NA 146 160 184 206
Total Common Equity 0 100,107 118 133 152
Shares Outstanding 102.60 102.60 102.60 102.60 102.60
Book Value Per Share 0.00 975.70 1.15 1.30 1.48